SNCA and Alzheimer disease: Alterations in α-synuclein dosage lead to familial PD, while α-synuclein also contributes to fibrilization of amyloid-β and tau, two key proteins in AD, which suggest a central role for α-synuclein toxicity in neurodegeneration (111).